Principal Financial Group
BHVN

Principal Financial Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Principal Financial Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,402
Closed -$2.48M – 2612
2022
Q3 		$2.48M Sell
16,402
-4,408
-21% -$653K ﹤0.01% 1683
2022
Q2 		$3.03M Sell
20,810
-4,762
-19% -$608K ﹤0.01% 1714
2022
Q1 		$3.03M Sell
25,572
-5,622
-18% -$701K ﹤0.01% 1800
2021
Q4 		$4.3M Sell
31,194
-3,576
-10% -$455K ﹤0.01% 1720
2021
Q3 		$4.83M Buy
34,770
+12,628
+57% +$1.58M ﹤0.01% 1700
2021
Q2 		$2.15M Sell
22,142
-165,728
-88% -$13.5M ﹤0.01% 1887
2021
Q1 		$12.8M Buy
187,870
+158,523
+540% +$12.8M 0.01% 1249
2020
Q4 		$2.52M Buy
29,347
+4,339
+17% +$368K ﹤0.01% 1753
2020
Q3 		$1.63M Sell
25,008
-87
-0.3% -$5.7K ﹤0.01% 1776
2020
Q2 		$1.83M Buy
25,095
+17,036
+211% +$907K ﹤0.01% 1714
2020
Q1 		$274K Sell
8,059
-4,630
-36% -$212K ﹤0.01% 1984
2019
Q4 		$691K Buy
12,689
+1,541
+14% +$76.3K ﹤0.01% 1885
2019
Q3 		$465K Buy
11,148
+5,216
+88% +$220K ﹤0.01% 1959
2019
Q2 		$260K Buy
5,932
+21
+0.4% +$1.18K ﹤0.01% 2093
2019
Q1 		$304K Buy
5,911
+371
+7% +$16K ﹤0.01% 2034
2018
Q4 		$205K Sell
5,540
-99
-2% -$3.57K ﹤0.01% 2127
2018
Q3 		$212K Buy
5,639
+276
+5% +$10.2K ﹤0.01% 2156
2018
Q2 		$212K Buy
+5,363
New +$170K ﹤0.01% 2153

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Principal Financial Group's BHVN Position: Q4 2022 in Review

Principal Financial Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 16,402 shares — an estimated $2.48M sold.

Principal Financial Group first reported a position in BHVN in Q2 2018 and held it in 18 quarters. The position peaked at $12.8M in Q1 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Principal Financial Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Principal Financial Group sold 16,402 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $2.48M.
  • Principal Financial Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2018 and held it in 18 quarters.
  • Principal Financial Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $12.8M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Principal Financial Group's 13F filing for Q4 2022, filed 9 Feb 2023.